Literature DB >> 21147877

Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes.

Riya Ganguly1, Kristin Schram, Xiangping Fang, Minsuk Kim, Brian Rodrigues, Farah S L Thong, Gary Sweeney.   

Abstract

Cardiomyocyte substrate utilization is important in maintaining optimal cardiac function. Adiponectin has been shown to confer cardioprotective effects in part via regulating glucose and fatty acid uptake and oxidation in cardiomyocytes. Here we investigated mechanisms whereby adiponectin mediates a particular metabolic effect by focusing on lipoprotein lipase (LPL), an enzyme that increases free fatty acid availability to the heart by breakdown of chylomicrons and very-low-density lipoproteins in circulation. We used primary adult rat cardiomyocytes and demonstrate that adiponectin increased LPL translocation to the cell surface where it could be released at least partly in its active form, as evidenced by measuring basal and heparin-releasable LPL activity. Furthermore, these effects of adiponectin were mediated via remodeling of the actin cytoskeleton. We quantitatively assessed the filamentous to globular actin ratio and show that increased stress fiber formation, visualized by rhodamine-phalloidin immunofluorescence, in response to adiponectin, is achieved via stimulating Ras homolog gene family A (RhoA) activity, determined using G-LISA RhoA activation assay kit. We also demonstrate that adiponectin induces phosphorylation and inhibition of cofilin, leading to a reduction in actin treadmilling. Increased cofilin phosphorylation and stress fiber formation in response to adiponectin were prevented by inhibition of either RhoA or its downstream kinase Rho-associated protein kinase. Importantly, inhibition of cytoskeletal remodeling prevented adiponectin-stimulated plasma membrane LPL content detected by immunofluorescence and also subsequent LPL activity. In summary, we show that adiponectin mediates actin cytoskeleton remodeling to translocate LPL and allow subsequent activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147877     DOI: 10.1210/en.2010-0530

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

2.  Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Authors:  Ronald B Goldberg; Marinella Temprosa; Lisa Mele; Trevor Orchard; Kieren Mather; George Bray; Edward Horton; Abbas Kitabchi; Jonathan Krakoff; Santica Marcovina; Leigh Perreault; Neil White
Journal:  Metabolism       Date:  2015-12-02       Impact factor: 8.694

Review 3.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

Review 4.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  HDL flux is higher in patients with nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen F Previs; Jaividhya Dasarathy; Kwangwon Lee; Abdullah Osme; Chunki Kim; Serguei Ilchenko; Shuhui W Lorkowski; Jonathan D Smith; Srinivasan Dasarathy; Takhar Kasumov
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-10       Impact factor: 4.310

6.  The cardio-protective signaling and mechanisms of adiponectin.

Authors:  Gayani Nanayakkara; Thiruchelvan Kariharan; Lili Wang; Juming Zhong; Rajesh Amin
Journal:  Am J Cardiovasc Dis       Date:  2012-10-20

7.  Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.

Authors:  R Goldberg; M Temprosa; J Otvos; J Brunzell; S Marcovina; K Mather; R Arakaki; K Watson; E Horton; E Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958

8.  Anfibatide Preserves Blood-Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat.

Authors:  Peng Gong; Rui Li; Hui-Yu Jia; Zheng Ma; Xiao-Yi Li; Xiang-Rong Dai; Sheng-Yong Luo
Journal:  J Mol Neurosci       Date:  2019-09-03       Impact factor: 3.444

9.  Adiponectin action: a combination of endocrine and autocrine/paracrine effects.

Authors:  Keith Dadson; Ying Liu; Gary Sweeney
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-08       Impact factor: 5.555

10.  QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats.

Authors:  Dong-Xin Tang; Hai-Ping Zhao; Chun-Shui Pan; Yu-Ying Liu; Xiao-Hong Wei; Xiao-Yuan Yang; Yuan-Yuan Chen; Jing-Yu Fan; Chuan-She Wang; Jing-Yan Han; Ping-Ping Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.